State of art in heart transplantation

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ŠPINAROVÁ Lenka

Year of publication 2011
Type Article in Periodical
Magazine / Source Interventional Medicine and Applied Science
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords heart transplantation; immunosuppression; rejection; echocardiography
Description Heart transplantation (HTX) has become an accepted treatment for selected patients with end-stage heart failure. There are two transplant centres in the Czech Republic, Prague since 1984 and Brno since 1992, in which more than 1000 heart transplantations were performed. Pharmacotherapy after heart transplantation includes the problems of immunosuppression and interactions of immunosuppressant drugs and their adverse effects. The main task for future is to find better immunosuppression with less side effects, to replace invasive bioptic examination of rejection and to find alternatives to clasical transplantation: xenotransplantation, stem cell transplantation or development of new ventricle assisst devices.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info